FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:PHF6-GPC3

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: PHF6-GPC3
FusionPDB ID: 64892
FusionGDB2.0 ID: 64892
HgeneTgene
Gene symbol

PHF6

GPC3

Gene ID

84295

2719

Gene namePHD finger protein 6glypican 3
SynonymsBFLS|BORJ|CENP-31DGSX|GTR2-2|MXR7|OCI-5|SDYS|SGB|SGBS|SGBS1
Cytomap

Xq26.2

Xq26.2

Type of geneprotein-codingprotein-coding
DescriptionPHD finger protein 6PHD-like zinc finger proteincentromere protein 31glypican-3glypican proteoglycan 3heparan sulphate proteoglycanintestinal protein OCI-5secreted glypican-3
Modification date2020031320200315
UniProtAcc.

P51654

Main function of 5'-partner protein: FUNCTION: Cell surface proteoglycan that bears heparan sulfate (PubMed:14610063). Negatively regulates the hedgehog signaling pathway when attached via the GPI-anchor to the cell surface by competing with the hedgehog receptor PTC1 for binding to hedgehog proteins (By similarity). Binding to the hedgehog protein SHH triggers internalization of the complex by endocytosis and its subsequent lysosomal degradation (By similarity). Positively regulates the canonical Wnt signaling pathway by binding to the Wnt receptor Frizzled and stimulating the binding of the Frizzled receptor to Wnt ligands (PubMed:16227623, PubMed:24496449). Positively regulates the non-canonical Wnt signaling pathway (By similarity). Binds to CD81 which decreases the availability of free CD81 for binding to the transcriptional repressor HHEX, resulting in nuclear translocation of HHEX and transcriptional repression (By similarity). Inhibits the dipeptidyl peptidase activity of DPP4 (PubMed:17549790). Plays a role in limb patterning and skeletal development by controlling the cellular response to BMP4 (By similarity). Modulates the effects of growth factors BMP2, BMP7 and FGF7 on renal branching morphogenesis (By similarity). Required for coronary vascular development (By similarity). Plays a role in regulating cell movements during gastrulation (By similarity). {ECO:0000250|UniProtKB:Q6V9Y8, ECO:0000250|UniProtKB:Q8CFZ4, ECO:0000269|PubMed:14610063, ECO:0000269|PubMed:16227623, ECO:0000269|PubMed:17549790, ECO:0000269|PubMed:24496449}.
Ensembl transtripts involved in fusion geneENST idsENST00000332070, ENST00000370799, 
ENST00000370800, ENST00000370803, 
ENST00000394292, ENST00000416404, 
ENST00000370818, ENST00000394299, 
ENST00000543339, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score3 X 3 X 2=1812 X 11 X 6=792
# samples 312
** MAII scorelog2(3/18*10)=0.736965594166206
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
log2(12/792*10)=-2.72246602447109
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: PHF6 [Title/Abstract] AND GPC3 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: PHF6 [Title/Abstract] AND GPC3 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)PHF6(133527982)-GPC3(132888203), # samples:1
Anticipated loss of major functional domain due to fusion event.PHF6-GPC3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
PHF6-GPC3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
PHF6-GPC3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
PHF6-GPC3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgenePHF6

GO:0000122

negative regulation of transcription by RNA polymerase II

24554700

TgeneGPC3

GO:0060828

regulation of canonical Wnt signaling pathway

14610063

TgeneGPC3

GO:0090263

positive regulation of canonical Wnt signaling pathway

24496449

TgeneGPC3

GO:2000050

regulation of non-canonical Wnt signaling pathway

14610063



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chrX:133527982/chrX:132888203)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across PHF6 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across GPC3 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000370803PHF6chrX133527982+ENST00000370818GPC3chrX132888203-24646792612084607
ENST00000370803PHF6chrX133527982+ENST00000394299GPC3chrX132888203-25246792612153630
ENST00000370803PHF6chrX133527982+ENST00000543339GPC3chrX132888203-20856792612084607
ENST00000332070PHF6chrX133527982+ENST00000370818GPC3chrX132888203-24056202022025607
ENST00000332070PHF6chrX133527982+ENST00000394299GPC3chrX132888203-24656202022094630
ENST00000332070PHF6chrX133527982+ENST00000543339GPC3chrX132888203-20266202022025608
ENST00000394292PHF6chrX133527982+ENST00000370818GPC3chrX132888203-24056202022025607
ENST00000394292PHF6chrX133527982+ENST00000394299GPC3chrX132888203-24656202022094630
ENST00000394292PHF6chrX133527982+ENST00000543339GPC3chrX132888203-20266202022025608
ENST00000370799PHF6chrX133527982+ENST00000370818GPC3chrX132888203-23976121942017607
ENST00000370799PHF6chrX133527982+ENST00000394299GPC3chrX132888203-24576121942086630
ENST00000370799PHF6chrX133527982+ENST00000543339GPC3chrX132888203-20186121942017608
ENST00000416404PHF6chrX133527982+ENST00000370818GPC3chrX132888203-22684831671888573
ENST00000416404PHF6chrX133527982+ENST00000394299GPC3chrX132888203-23284831671957596
ENST00000416404PHF6chrX133527982+ENST00000543339GPC3chrX132888203-18894831671888574
ENST00000370800PHF6chrX133527982+ENST00000370818GPC3chrX132888203-23445591411964607
ENST00000370800PHF6chrX133527982+ENST00000394299GPC3chrX132888203-24045591412033630
ENST00000370800PHF6chrX133527982+ENST00000543339GPC3chrX132888203-19655591411964607

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000370803ENST00000370818PHF6chrX133527982+GPC3chrX132888203-0.0016556110.9983444
ENST00000370803ENST00000394299PHF6chrX133527982+GPC3chrX132888203-0.0016508890.9983491
ENST00000370803ENST00000543339PHF6chrX133527982+GPC3chrX132888203-0.0023166660.9976833
ENST00000332070ENST00000370818PHF6chrX133527982+GPC3chrX132888203-0.001754790.99824524
ENST00000332070ENST00000394299PHF6chrX133527982+GPC3chrX132888203-0.0017536930.9982463
ENST00000332070ENST00000543339PHF6chrX133527982+GPC3chrX132888203-0.0024929210.99750715
ENST00000394292ENST00000370818PHF6chrX133527982+GPC3chrX132888203-0.001754790.99824524
ENST00000394292ENST00000394299PHF6chrX133527982+GPC3chrX132888203-0.0017536930.9982463
ENST00000394292ENST00000543339PHF6chrX133527982+GPC3chrX132888203-0.0024929210.99750715
ENST00000370799ENST00000370818PHF6chrX133527982+GPC3chrX132888203-0.0017393490.9982607
ENST00000370799ENST00000394299PHF6chrX133527982+GPC3chrX132888203-0.0017403120.9982597
ENST00000370799ENST00000543339PHF6chrX133527982+GPC3chrX132888203-0.0024611660.9975388
ENST00000416404ENST00000370818PHF6chrX133527982+GPC3chrX132888203-0.000897990.999102
ENST00000416404ENST00000394299PHF6chrX133527982+GPC3chrX132888203-0.0011481060.9988519
ENST00000416404ENST00000543339PHF6chrX133527982+GPC3chrX132888203-0.0014155650.9985845
ENST00000370800ENST00000370818PHF6chrX133527982+GPC3chrX132888203-0.0016267480.99837327
ENST00000370800ENST00000394299PHF6chrX133527982+GPC3chrX132888203-0.0016346590.99836534
ENST00000370800ENST00000543339PHF6chrX133527982+GPC3chrX132888203-0.0022929450.997707

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for PHF6-GPC3

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
PHF6chrX133527982GPC3chrX132888203483105YCRKHKKTAHNSEEAFEIVVRHAKNY
PHF6chrX133527982GPC3chrX132888203559139YCRKHKKTAHNSEEAFEIVVRHAKNY
PHF6chrX133527982GPC3chrX132888203612139YCRKHKKTAHNSEEAFEIVVRHAKNY
PHF6chrX133527982GPC3chrX132888203620139YCRKHKKTAHNSEEAFEIVVRHAKNY
PHF6chrX133527982GPC3chrX132888203679139YCRKHKKTAHNSEEAFEIVVRHAKNY

Top

Potential FusionNeoAntigen Information of PHF6-GPC3 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
PHF6-GPC3_133527982_132888203.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
PHF6-GPC3chrX133527982chrX132888203620HLA-B38:02AHNSEEAF0.9910.9808816
PHF6-GPC3chrX133527982chrX132888203620HLA-B38:01AHNSEEAF0.99030.977816
PHF6-GPC3chrX133527982chrX132888203620HLA-B18:01EEAFEIVV0.9810.96481220
PHF6-GPC3chrX133527982chrX132888203620HLA-B15:18AHNSEEAF0.9510.9401816
PHF6-GPC3chrX133527982chrX132888203620HLA-B45:01SEEAFEIVV0.99780.94541120
PHF6-GPC3chrX133527982chrX132888203620HLA-B50:02SEEAFEIVV0.99560.68751120
PHF6-GPC3chrX133527982chrX132888203620HLA-B35:08TAHNSEEAF0.99090.9258716
PHF6-GPC3chrX133527982chrX132888203620HLA-B35:01TAHNSEEAF0.97430.9409716
PHF6-GPC3chrX133527982chrX132888203620HLA-B35:05TAHNSEEAF0.95240.8473716
PHF6-GPC3chrX133527982chrX132888203620HLA-B46:01TAHNSEEAF0.94450.6543716
PHF6-GPC3chrX133527982chrX132888203620HLA-B35:03TAHNSEEAF0.86190.9311716
PHF6-GPC3chrX133527982chrX132888203620HLA-B41:01SEEAFEIVV0.56850.9631120
PHF6-GPC3chrX133527982chrX132888203620HLA-B50:01SEEAFEIVV0.51660.71541120
PHF6-GPC3chrX133527982chrX132888203620HLA-B35:02TAHNSEEAF0.43040.9828716
PHF6-GPC3chrX133527982chrX132888203620HLA-B35:04TAHNSEEAF0.43040.9828716
PHF6-GPC3chrX133527982chrX132888203620HLA-B39:13SEEAFEIVV0.23290.92141120
PHF6-GPC3chrX133527982chrX132888203620HLA-B38:01AHNSEEAFEI0.99660.9408818
PHF6-GPC3chrX133527982chrX132888203620HLA-B38:02AHNSEEAFEI0.99650.9517818
PHF6-GPC3chrX133527982chrX132888203620HLA-B57:03KTAHNSEEAF0.98880.9879616
PHF6-GPC3chrX133527982chrX132888203620HLA-B18:01EEAFEIVVRH0.83640.87971222
PHF6-GPC3chrX133527982chrX132888203620HLA-B40:06SEEAFEIVV0.99750.69381120
PHF6-GPC3chrX133527982chrX132888203620HLA-B44:10SEEAFEIVV0.99140.55391120
PHF6-GPC3chrX133527982chrX132888203620HLA-B15:21TAHNSEEAF0.98950.9264716
PHF6-GPC3chrX133527982chrX132888203620HLA-B15:31TAHNSEEAF0.9780.9355716
PHF6-GPC3chrX133527982chrX132888203620HLA-C12:12TAHNSEEAF0.70340.9497716
PHF6-GPC3chrX133527982chrX132888203620HLA-B39:08SEEAFEIVV0.45130.93991120
PHF6-GPC3chrX133527982chrX132888203620HLA-B35:12TAHNSEEAF0.43040.9828716
PHF6-GPC3chrX133527982chrX132888203620HLA-C03:14TAHNSEEAF0.34090.9628716
PHF6-GPC3chrX133527982chrX132888203620HLA-B38:05AHNSEEAF0.99030.977816
PHF6-GPC3chrX133527982chrX132888203620HLA-B18:05EEAFEIVV0.9810.96481220
PHF6-GPC3chrX133527982chrX132888203620HLA-B18:03EEAFEIVV0.96480.96191220
PHF6-GPC3chrX133527982chrX132888203620HLA-B39:11AHNSEEAF0.92040.9357816
PHF6-GPC3chrX133527982chrX132888203620HLA-B40:04SEEAFEIVV0.99180.7771120
PHF6-GPC3chrX133527982chrX132888203620HLA-C03:02TAHNSEEAF0.98850.9761716
PHF6-GPC3chrX133527982chrX132888203620HLA-B35:11TAHNSEEAF0.98730.9288716
PHF6-GPC3chrX133527982chrX132888203620HLA-B15:11TAHNSEEAF0.97920.8963716
PHF6-GPC3chrX133527982chrX132888203620HLA-B35:28TAHNSEEAF0.97850.969716
PHF6-GPC3chrX133527982chrX132888203620HLA-B15:08TAHNSEEAF0.97760.8893716
PHF6-GPC3chrX133527982chrX132888203620HLA-B35:77TAHNSEEAF0.97430.9409716
PHF6-GPC3chrX133527982chrX132888203620HLA-B35:23TAHNSEEAF0.97380.9467716
PHF6-GPC3chrX133527982chrX132888203620HLA-B35:43TAHNSEEAF0.97270.8901716
PHF6-GPC3chrX133527982chrX132888203620HLA-B35:20TAHNSEEAF0.96960.9709716
PHF6-GPC3chrX133527982chrX132888203620HLA-B35:30TAHNSEEAF0.9590.9147716
PHF6-GPC3chrX133527982chrX132888203620HLA-B35:17TAHNSEEAF0.9590.9147716
PHF6-GPC3chrX133527982chrX132888203620HLA-B35:24TAHNSEEAF0.90890.9161716
PHF6-GPC3chrX133527982chrX132888203620HLA-B35:13TAHNSEEAF0.84090.9379716
PHF6-GPC3chrX133527982chrX132888203620HLA-C16:04TAHNSEEAF0.82290.9708716
PHF6-GPC3chrX133527982chrX132888203620HLA-C12:02TAHNSEEAF0.81310.9457716
PHF6-GPC3chrX133527982chrX132888203620HLA-B18:06EEAFEIVVR0.76160.95151221
PHF6-GPC3chrX133527982chrX132888203620HLA-C03:06TAHNSEEAF0.7120.9913716
PHF6-GPC3chrX133527982chrX132888203620HLA-B41:03SEEAFEIVV0.66690.72651120
PHF6-GPC3chrX133527982chrX132888203620HLA-B50:05SEEAFEIVV0.51660.71541120
PHF6-GPC3chrX133527982chrX132888203620HLA-B50:04SEEAFEIVV0.51660.71541120
PHF6-GPC3chrX133527982chrX132888203620HLA-B35:09TAHNSEEAF0.43040.9828716
PHF6-GPC3chrX133527982chrX132888203620HLA-C16:01TAHNSEEAF0.2230.9771716
PHF6-GPC3chrX133527982chrX132888203620HLA-B57:04KTAHNSEEAF0.9990.7643616
PHF6-GPC3chrX133527982chrX132888203620HLA-B38:05AHNSEEAFEI0.99660.9408818
PHF6-GPC3chrX133527982chrX132888203620HLA-B57:02KTAHNSEEAF0.99410.9014616
PHF6-GPC3chrX133527982chrX132888203620HLA-B18:05EEAFEIVVRH0.83640.87971222
PHF6-GPC3chrX133527982chrX132888203620HLA-B18:08EEAFEIVVRH0.82190.73011222
PHF6-GPC3chrX133527982chrX132888203620HLA-B18:11EEAFEIVVRH0.81920.80151222
PHF6-GPC3chrX133527982chrX132888203620HLA-B18:06EEAFEIVVRH0.79220.89821222
PHF6-GPC3chrX133527982chrX132888203620HLA-B18:03EEAFEIVVRH0.73880.87081222

Top

Potential FusionNeoAntigen Information of PHF6-GPC3 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
PHF6-GPC3_133527982_132888203.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
PHF6-GPC3chrX133527982chrX132888203620DRB1-0813SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-0813NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-0815SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-0815NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-0830SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-0830NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-0837SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-0837NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1101SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1101NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1105SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1105NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1108SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1108NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1109SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1109NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1110SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1110NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1111SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1111NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1112SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1112NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1114SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1114NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1115SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1115NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1119SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1119NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1120SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1120NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1124SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1124NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1127SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1127NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1128SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1128NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1129SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1129NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1131SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1131NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1132SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1132NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1133SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1133NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1139SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1139NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1145SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1145NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1149SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1149NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1151SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1151NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1153SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1161SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1161NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1162SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1162NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1164SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1164NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1166SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1166NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1168SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1168NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1169SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1169NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1172SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1172NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1173SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1173NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1174SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1174NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1175SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1175NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1179SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1180SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1180NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1181SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1181NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1182SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1182NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1186SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1186NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1187SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1187NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1190SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1190NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1191SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1191NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1193SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1194SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1194NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1195SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1195NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1196SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1196NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1302SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1302NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1305SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1305NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1314SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1314NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1316SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1316NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1323SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1323NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1326SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1326NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1329SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1329NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1330SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1330NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1334SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1334NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1336SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1336NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1337SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1338SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1339SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1339NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1341SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1341NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1347SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1350SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1350NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1356SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1356NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1360SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1360NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1362SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1362NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1363SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1363NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1365SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1366SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1373SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1373NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1374SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1374NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1382SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1382NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1385SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1385NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1386SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1386NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1396SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1396NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1397SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1397NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1399SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1399NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1402SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1403SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1403NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1424SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1427SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1427NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1430SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1430NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1440SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1440NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1441SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1442SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1442NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1451SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1453SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1463SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1463NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1467SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1467NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1477SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1477NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1485SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1485NSEEAFEIVVRHAKN1025
PHF6-GPC3chrX133527982chrX132888203620DRB1-1489SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1494SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1498SEEAFEIVVRHAKNY1126
PHF6-GPC3chrX133527982chrX132888203620DRB1-1498NSEEAFEIVVRHAKN1025

Top

Fusion breakpoint peptide structures of PHF6-GPC3

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
4620KTAHNSEEAFEIVVPHF6GPC3chrX133527982chrX132888203620

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of PHF6-GPC3

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN4620KTAHNSEEAFEIVV-7.9962-8.1096
HLA-B14:023BVN4620KTAHNSEEAFEIVV-5.70842-6.74372
HLA-B52:013W394620KTAHNSEEAFEIVV-6.83737-6.95077
HLA-B52:013W394620KTAHNSEEAFEIVV-4.4836-5.5189
HLA-A11:014UQ24620KTAHNSEEAFEIVV-10.0067-10.1201
HLA-A11:014UQ24620KTAHNSEEAFEIVV-9.03915-10.0745
HLA-A24:025HGA4620KTAHNSEEAFEIVV-6.56204-6.67544
HLA-A24:025HGA4620KTAHNSEEAFEIVV-5.42271-6.45801
HLA-B44:053DX84620KTAHNSEEAFEIVV-7.85648-8.89178
HLA-B44:053DX84620KTAHNSEEAFEIVV-5.3978-5.5112
HLA-A02:016TDR4620KTAHNSEEAFEIVV-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of PHF6-GPC3

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
PHF6-GPC3chrX133527982chrX1328882031120SEEAFEIVVCCGAAGAGGCCTTTGAAATTGTTGTTC
PHF6-GPC3chrX133527982chrX1328882031220EEAFEIVVAAGAGGCCTTTGAAATTGTTGTTC
PHF6-GPC3chrX133527982chrX1328882031221EEAFEIVVRAAGAGGCCTTTGAAATTGTTGTTCGCC
PHF6-GPC3chrX133527982chrX1328882031222EEAFEIVVRHAAGAGGCCTTTGAAATTGTTGTTCGCCATG
PHF6-GPC3chrX133527982chrX132888203616KTAHNSEEAFAAACTGCACATAACTCCGAAGAGGCCTTTG
PHF6-GPC3chrX133527982chrX132888203716TAHNSEEAFCTGCACATAACTCCGAAGAGGCCTTTG
PHF6-GPC3chrX133527982chrX132888203816AHNSEEAFCACATAACTCCGAAGAGGCCTTTG
PHF6-GPC3chrX133527982chrX132888203818AHNSEEAFEICACATAACTCCGAAGAGGCCTTTGAAATTG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
PHF6-GPC3chrX133527982chrX1328882031025NSEEAFEIVVRHAKNACTCCGAAGAGGCCTTTGAAATTGTTGTTCGCCATGCCAAGAACT
PHF6-GPC3chrX133527982chrX1328882031126SEEAFEIVVRHAKNYCCGAAGAGGCCTTTGAAATTGTTGTTCGCCATGCCAAGAACTACA

Top

Information of the samples that have these potential fusion neoantigens of PHF6-GPC3

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
BLCAPHF6-GPC3chrX133527982ENST00000332070chrX132888203ENST00000370818TCGA-BL-A0C8-01A

Top

Potential target of CAR-T therapy development for PHF6-GPC3

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to PHF6-GPC3

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to PHF6-GPC3

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource